Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine effect on sufentanil EC50 for blunting intubation response in bariatric surgery
ChiCTR2200064981Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Oct 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine and sufentanil in obesity (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: mean arterial pressure and heart rate. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
lidocainesufentanil
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2200064981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064981.